ATE113846T1 - Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. - Google Patents
Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.Info
- Publication number
- ATE113846T1 ATE113846T1 AT89908090T AT89908090T ATE113846T1 AT E113846 T1 ATE113846 T1 AT E113846T1 AT 89908090 T AT89908090 T AT 89908090T AT 89908090 T AT89908090 T AT 89908090T AT E113846 T1 ATE113846 T1 AT E113846T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- therapeutic compositions
- myocardial infarcts
- myocardial
- infarcts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20966588A | 1988-06-21 | 1988-06-21 | |
US23759588A | 1988-08-25 | 1988-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE113846T1 true ATE113846T1 (de) | 1994-11-15 |
Family
ID=26904371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89908090T ATE113846T1 (de) | 1988-06-21 | 1989-06-14 | Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0420937B1 (de) |
JP (1) | JP2749167B2 (de) |
AT (1) | ATE113846T1 (de) |
CA (1) | CA1340633C (de) |
DE (1) | DE68919361T2 (de) |
WO (1) | WO1989012463A1 (de) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843442A (en) * | 1990-10-22 | 1998-12-01 | Corvas International, Inc. | Blood coagulation protein antagonists and uses therefor |
US5879677A (en) * | 1992-12-09 | 1999-03-09 | The Scripps Research Institute | Method for inhibition of cerebral tissue factor mediated reperfusion damage |
US7122636B1 (en) | 1997-02-21 | 2006-10-17 | Genentech, Inc. | Antibody fragment-polymer conjugates and uses of same |
US20060235209A9 (en) | 1997-03-10 | 2006-10-19 | Jin-An Jiao | Use of anti-tissue factor antibodies for treating thromboses |
US5986065A (en) * | 1997-03-10 | 1999-11-16 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
US20030109680A1 (en) | 2001-11-21 | 2003-06-12 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
US7749498B2 (en) | 1997-03-10 | 2010-07-06 | Genentech, Inc. | Antibodies for inhibiting blood coagulation and methods of use thereof |
US6703494B2 (en) | 2000-03-16 | 2004-03-09 | Genentech, Inc. | Anti-tissue factor antibodies with enhanced anticoagulant potency |
ES2319636T3 (es) | 2002-02-05 | 2009-05-11 | Genentech, Inc. | Purificacion de proteinas. |
PT3095793T (pt) | 2003-07-28 | 2020-05-04 | Genentech Inc | Redução da lixiviação de proteína a durante a cromatografia por afinidade com proteína a |
US7655229B2 (en) | 2004-09-02 | 2010-02-02 | Chan Andrew C | Anti-FC-gamma RIIB receptor antibody and uses therefor |
US7662926B2 (en) | 2004-09-02 | 2010-02-16 | Genentech, Inc. | Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
FR2902799B1 (fr) | 2006-06-27 | 2012-10-26 | Millipore Corp | Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide |
US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
WO2008079280A1 (en) | 2006-12-21 | 2008-07-03 | Millipore Corporation | Purification of proteins |
CA2673851C (en) | 2007-01-22 | 2016-05-03 | Genentech, Inc. | Polyelectrolyte precipitation and purification of proteins |
ES2751022T3 (es) | 2007-07-09 | 2020-03-30 | Genentech Inc | Prevención de la reducción de enlaces disulfuro durante la producción recombinante de polipéptidos |
CA2703279C (en) | 2007-10-30 | 2014-04-22 | Genentech, Inc. | Antibody purification by cation exchange chromatography |
WO2009151514A1 (en) | 2008-06-11 | 2009-12-17 | Millipore Corporation | Stirred tank bioreactor |
ES2749190T3 (es) | 2008-08-14 | 2020-03-19 | Genentech Inc | Métodos para eliminar un contaminante usando cromatografía de membrana de intercambio iónico de desplazamiento de proteínas indígenas |
BRPI0918978A2 (pt) | 2008-09-10 | 2015-12-01 | Genentech Inc | composições e métodos a prevenção da degradação oxidativa das proteínas |
UA109633C2 (uk) | 2008-12-09 | 2015-09-25 | Антитіло людини проти тканинного фактора | |
JP2012512244A (ja) | 2008-12-16 | 2012-05-31 | イー・エム・デイー・ミリポア・コーポレイシヨン | タンパク質の精製 |
CN105037535A (zh) | 2008-12-16 | 2015-11-11 | Emd密理博公司 | 搅拌槽反应器及方法 |
ES2547712T3 (es) | 2009-02-27 | 2015-10-08 | Genentech, Inc. | Métodos y composiciones para el marcado de proteínas |
CN104059955A (zh) | 2009-08-11 | 2014-09-24 | 弗·哈夫曼-拉罗切有限公司 | 在无谷氨酰胺的细胞培养基中的蛋白质生产 |
BR112012004697B8 (pt) | 2009-09-01 | 2021-05-25 | Genentech Inc | método para purificar um polipeptídeo compreendendo uma região ch2/ch3 |
CN106983862A (zh) | 2010-03-22 | 2017-07-28 | 弗·哈夫曼-拉罗切有限公司 | 对于稳定含有蛋白质的制剂有用的组合物和方法 |
MX2012012743A (es) | 2010-05-03 | 2012-11-23 | Genentech Inc | Composiciones y metodos utiles para reducir la viscosidad de formulaciones que contienen proteina. |
KR101551295B1 (ko) | 2010-05-17 | 2015-09-08 | 이엠디 밀리포어 코포레이션 | 생체분자 정제용 자극 반응성 중합체 |
CN102985437B (zh) | 2010-05-28 | 2016-05-25 | 弗·哈夫曼-拉罗切有限公司 | 通过下调ldh和pdhk表达降低乳酸水平和增加多肽生产 |
CN111012921A (zh) | 2010-06-15 | 2020-04-17 | 根马布股份公司 | 针对组织因子的人抗体药物缀合物 |
KR102058307B1 (ko) | 2010-06-24 | 2019-12-20 | 제넨테크, 인크. | 단백질-함유 제제를 안정화시키기 위한 알킬글리코시드 함유 조성물 및 방법 |
MX2013001267A (es) | 2010-08-13 | 2013-04-10 | Genentech Inc | ANTICUERPOS A IL-1ß E EIL-18 PARA TRATAMIENTO DE ENFERMEDAD. |
WO2012030512A1 (en) | 2010-09-03 | 2012-03-08 | Percivia Llc. | Flow-through protein purification process |
CN103649297B (zh) | 2011-07-08 | 2017-03-01 | Emd密理博公司 | 用于一次性生物技术方法的改良深层滤器 |
KR102067075B1 (ko) | 2011-12-22 | 2020-01-17 | 제넨테크, 인크. | 이온 교환 막 크로마토그래피 |
CN109880867A (zh) | 2012-03-27 | 2019-06-14 | 弗·哈夫曼-拉罗切有限公司 | 用于重组蛋白质的改进的收获操作 |
EP3427721A1 (de) | 2012-05-18 | 2019-01-16 | Genentech, Inc. | Hochkonzentrierte monoklonale antikörperformulierungen |
EP2934602B1 (de) | 2012-12-19 | 2019-02-27 | Genentech, Inc. | Verfahren und zusammensetzungen zur radiohalogen proteinmarkierung |
EP3166401B1 (de) | 2014-07-09 | 2020-08-19 | F. Hoffmann-La Roche AG | Ph-einstellung zur verbesserung der auftaurückgewinnung von zellbänken |
JOP20170013B1 (ar) | 2016-01-22 | 2021-08-17 | Merck Sharp & Dohme | أجسام xi مضادة لعامل مضاد للتجلط |
AU2017242031B2 (en) | 2016-03-29 | 2023-07-27 | Geltor, Inc. | Expression of proteins in gram-negative bacteria wherein the ratio of periplasmic volume to cytoplasmic volume is between 0.5:1 and 10:1 |
KR102218714B1 (ko) | 2016-06-14 | 2021-02-24 | 머크 샤프 앤드 돔 코포레이션 | 항응고 인자 xi 항체 |
KR102579836B1 (ko) | 2016-12-22 | 2023-09-15 | 제넨테크, 인크. | 동결건조된 폴리펩타이드의 재구성 시간을 감소시키기 위한 방법 및 제제 |
US11180541B2 (en) | 2017-09-28 | 2021-11-23 | Geltor, Inc. | Recombinant collagen and elastin molecules and uses thereof |
EA202092904A1 (ru) | 2018-07-03 | 2021-04-22 | Бристол-Маерс Сквибб Компани | Способы получения рекомбинантных белков |
WO2020076776A1 (en) | 2018-10-10 | 2020-04-16 | Boehringer Ingelheim International Gmbh | Method for membrane gas transfer in high density bioreactor culture |
WO2020205716A1 (en) | 2019-04-01 | 2020-10-08 | Genentech, Inc. | Compositions and methods for stabilizing protein-containing formulations |
CN113993885A (zh) | 2019-04-12 | 2022-01-28 | 格尔托公司 | 重组弹性蛋白及其生产 |
CN114514311A (zh) | 2019-08-01 | 2022-05-17 | 百时美施贵宝公司 | 改进补料分批细胞培养物中蛋白质产量的方法 |
US20230357815A1 (en) | 2020-09-22 | 2023-11-09 | Bristol-Myers Squibb Company | Methods for increasing productivity of therapeutic proteins |
WO2023015234A1 (en) | 2021-08-05 | 2023-02-09 | Bristol-Myers Squibb Company | Cell culture methods for producing therapeutic proteins |
WO2023049687A1 (en) | 2021-09-21 | 2023-03-30 | Bristol-Myers Squibb Company | Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB2148299B (en) * | 1983-09-01 | 1988-01-06 | Hybritech Inc | Antibody compositions of therapeutic agents having an extended serum half-life |
US5009888A (en) * | 1987-04-13 | 1991-04-23 | Genzyme Corporation | Therapeutic enzyme-antibody complexes |
-
1989
- 1989-06-14 JP JP1507525A patent/JP2749167B2/ja not_active Expired - Lifetime
- 1989-06-14 AT AT89908090T patent/ATE113846T1/de not_active IP Right Cessation
- 1989-06-14 DE DE68919361T patent/DE68919361T2/de not_active Expired - Lifetime
- 1989-06-14 EP EP89908090A patent/EP0420937B1/de not_active Expired - Lifetime
- 1989-06-14 WO PCT/US1989/002598 patent/WO1989012463A1/en active IP Right Grant
- 1989-06-21 CA CA000603554A patent/CA1340633C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1989012463A1 (en) | 1989-12-28 |
EP0420937B1 (de) | 1994-11-09 |
EP0420937A1 (de) | 1991-04-10 |
JP2749167B2 (ja) | 1998-05-13 |
JPH03505329A (ja) | 1991-11-21 |
DE68919361T2 (de) | 1995-05-24 |
DE68919361D1 (de) | 1994-12-15 |
CA1340633C (en) | 1999-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE113846T1 (de) | Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. | |
ATE113834T1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
DE69027865T2 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
DE3885419D1 (de) | Für die direkte Expression von aktiviertem menschlichen Protein-C verwendbare Vektoren und Zusammensetzungen. | |
ATE218854T1 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
EP0119161A3 (en) | Benzazoquinone and benzazoninone derivatives, process for their preparation, their pharmaceutical preparations as well as their therapeutic use | |
DE3587741D1 (de) | Behandlung von Hautkrankheiten. | |
GR900100326A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof | |
DE3882775T2 (de) | Zusammensetzung zur Behandlung von parodontaler Krankheit. | |
IT9067434A0 (it) | Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento | |
IT8868118A0 (it) | Composizione e procedimento per il trattamento e la cura dei capelli | |
ATE132187T1 (de) | Fledermausspeichel-plasminogenaktivator vpa-alpha 1 | |
FR2651435B1 (de) | ||
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
DE3751218T2 (de) | Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen. | |
FR2612775B1 (fr) | Compositions pour la prevention et le traitement de la degenerescence cutanee | |
ES2042529T4 (es) | Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa. | |
DE3687233T2 (de) | Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten. | |
DE68905076T2 (de) | Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden. | |
SE8402199D0 (sv) | Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten | |
ATE75938T1 (de) | Enantiomere des propafenons enthaltende therapeutische mittel. | |
IT8467183A1 (it) | Composizione farmaceutica per la profilassi ed il trattamento dell'arteriosclerosi. | |
OA09469A (fr) | Utilisation d'un polypeptide ayant l'activité de l'interféron gamma pour la préparation de compositions pharmaceutiques destinées au traitement de cancers primitifs de la plèvre. | |
ATE75617T1 (de) | Behandlung gewebedegenerativer entzuendungskrankheiten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |